You, Homerbedloe and Hylander had insightful thoughts. Chuck is a great guy. We still interact on Facebook, but I’m not in agreement with much of what he posted here. Generex/ NuGen Immuno has significant oncology results as seen in the 10 year data for AE37 as a breast cancer vaccine. That supports and enhances the multi year prostate vaccine data illustrating the very long immuno effect and efficacy of the Ii-Key peptide approach. Once Generex moves from submitting and IND into the clinic they can prove major advantages over impotent and high risk mRNA vaccines. This is all real, but the pandemic really hurt most companies in moving forward unless Fauci plucked you out.